Northgate Capital
Casey Gordon has been part of Northgate since 2016 as a member of the firms Operating Committee, with a key role supporting Northgate’s business development and global marketing programs. Mr. Gordon serves as the Managing Partner of Northgate. Mr. Gordon is also the Head of Private Investments at The Capital Partnership (“TCP”) Group of Companies where he has worked since 2006. He is responsible for private equity investments and new business development, including work on corporate initiatives like the acquisition and oversight of Northgate Capital. Mr. Gordon has led investments for TCP across a number of sectors including financial services, healthcare and technology.
Mr. Gordon is also currently a member of the Board of Directors for TCP portfolio companies, Atia Vision and Supira Medical. Previously, he was a member of the Board of Directors for NuVera Medical until December 2020 when NuVera was sold to a multi-national medical device company.
Mr. Gordon holds a BA in Sociology from Johns Hopkins University and an MBA from the MIT Sloan School of Management.
This person is not in any offices
Northgate Capital
1 followers
Northgate Capital, founded in 2000, manages $4.8bn in venture capital and private equity. They distinguish themselves through their partnership approach to supporting the rapid growth of smart, daring and resilient companies looking to build global platforms. They work closely with strategic partners committed to growth, staying ahead and scaling the potential of disruptive innovations. Since inception, Northgate has a demonstrated track record of delivering outperforming returns to its investors.